Guangzhou Qianxiang Trading Co., Ltd. – Trademark Portfolio
Entity Type: 99
Guangzhou Qianxiang Trading Co., Ltd. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 18 (Leather Goods) — 5 filings in this category. The portfolio also extends into Class 20 (Furniture) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include NEYOXAS, MANMAXIM, SLIMWALT, and CARDCABIN. The owner is based in Guangzhou.
728,3rd Floor,Room 301,No.36,Chengjie
Nanshe Street,Yuancun,Tianhe District
Guangzhou 510000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Guangzhou Qianxiang Trading Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does Guangzhou Qianxiang Trading Co., Ltd. have?
Guangzhou Qianxiang Trading Co., Ltd. has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does Guangzhou Qianxiang Trading Co., Ltd. file in?
Guangzhou Qianxiang Trading Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 18 (Leather Goods), Class 20 (Furniture). Class 18 covers leather and imitations of leather; animal skins, hides; trunks and travelling bags.
What are Guangzhou Qianxiang Trading Co., Ltd.'s most well-known trademarks?
Guangzhou Qianxiang Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as NEYOXAS, MANMAXIM, SLIMWALT, and CARDCABIN. These are among 6 currently registered trademarks in the portfolio.
What is Guangzhou Qianxiang Trading Co., Ltd.'s trademark registration success rate?
Guangzhou Qianxiang Trading Co., Ltd. has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.